> For the complete documentation index, see [llms.txt](https://covid19.gitbook.io/novedades-covid-19/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://covid19.gitbook.io/novedades-covid-19/bibliografia-1.md).

# BIBLIOGRAFÍA

1\.        Liu Y, Ning Z, Chen Y, Guo M, Liu Y, Gali NK, et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature \[Internet]. 2020 Apr 27; Available from: <http://www.nature.com/articles/s41586-020-2271-3>

2\.        Li Y-C, Bai W-Z, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol \[Internet]. 2020 Feb 27; Available from: <http://www.ncbi.nlm.nih.gov/pubmed/32104915>

3\.        Esposito G, Pesce M, Seguella L, Sanseverino W, Lu J, Sarnelli G. Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion? Brain Behav Immun \[Internet]. 2020 Apr; Available from: <https://linkinghub.elsevier.com/retrieve/pii/S0889159120306449>

4\.        Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv. 2020;2020.02.22.20026500.&#x20;

5\.        Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain–Barré Syndrome Associated with SARS-CoV-2. N Engl J Med \[Internet]. 2020 Apr 17;NEJMc2009191. Available from: <http://www.nejm.org/doi/10.1056/NEJMc2009191>

6\.        Sociedad Española Neurologia. Recomendaciones de la Sociedad Española de Neurología (SEN) en relación con la pérdida de olfato como posible síntoma precoz de infección por CoVID-19 \[Internet]. 2020. Available from: <http://www.sen.es/attachments/article/2663/Recomendaciones> de la Sociedad Española de Neurología (SEN) en relación con la pérdida de olfato como posible síntoma precoz de infección por CoVID-19.pdf

7\.        Rello J, Storti E, Belliato M, Serrano R. Clinical phenotypes of SARS-CoV-2: Implications for clinicians and researchers. Eur Respir J \[Internet]. 2020 Apr 27;2001028. Available from: <http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01028-2020>

8\.        Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;1–8.&#x20;

9\.        Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz \[Internet]. 2020 Mar 5; Available from: <http://link.springer.com/10.1007/s00059-020-04909-z>

10\.      Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost \[Internet]. 2020; Available from: <http://www.ncbi.nlm.nih.gov/pubmed/32271988>

11\.      Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res \[Internet]. 2020 Apr; Available from: <https://linkinghub.elsevier.com/retrieve/pii/S0049384820301201>

12\.      Bozzani A, Arici V, Franciscone MM, Danesino V, Cascina A, Ticozzelli G, et al. SARSCoV-2 infection and the upper limbs deep vein thrombosis risk. Ann Vasc Surg \[Internet]. 2020 Apr; Available from: <https://linkinghub.elsevier.com/retrieve/pii/S0890509620303563>

13\.      Ali H, Daoud A, Mohamed MM, Salim SA, Yessayan L, Baharani J, et al. Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis. Ren Fail \[Internet]. 2020 Jan 1;42(1):393–7. Available from: <https://www.tandfonline.com/doi/full/10.1080/0886022X.2020.1756323>

14\.      Bordi L, Nicastri E, Scorzolini L, Di Caro A, Capobianchi MR, Castilletti C, et al. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020. Eurosurveillance \[Internet]. 2020;25(8):2–5. Available from: <https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.8.2000170>

15\.      Cevik M, Bamford C, Ho A. COVID-19 pandemic – A focused review for clinicians. Clin Microbiol Infect \[Internet]. 2020 Apr; Available from: <https://linkinghub.elsevier.com/retrieve/pii/S1198743X20302317>

16\.      Li Gang, Chen M J, Chen W  et al. Variation in the titer of the specific IgG antibody in patients with SARS. Li Gang, Chen M J, Chen W, al. 2003;283–5.&#x20;

17\.      Chan KH, Cheng VCC, Woo PCY, Lau SKP, Poon LLM, Guan Y, et al. Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Clin Diagn Lab Immunol \[Internet]. 2005 Nov;12(11):1317–21. Available from: <http://www.ncbi.nlm.nih.gov/pubmed/16275947>

18\.      Xun J, Lu L, Jiang S, Lu H, Wen Y, Huang J. patient cohort and their implications. 2020;&#x20;

19\.      Bao L, Deng W, Gao H, Xiao C, Liu J, Xue J, et al. Reinfection could not occur in SARS-CoV-2 infected rhesus macaques. bioRxiv. 2020;2020.03.13.990226.&#x20;

20\.      Three C, Central G, Public T, Hospital TS, Authors C, Huang A. Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice. 2020;&#x20;

21\.      Qu J, Wu C, Li X, Zhang G, Jiang Z, Li X, et al. Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis \[Internet]. 2020 Apr 27; Available from: <https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa489/5825506>

22\.      Zhou L, Liu K, Liu HG. Cause analysis and treatment strategies of “recurrence” with novel coronavirus pneumonia (covid-19) patients after discharge from hospital. Zhonghua Jie He He Hu Xi Za Zhi \[Internet]. 2020 Mar 2;43:E028. Available from: <http://www.ncbi.nlm.nih.gov/pubmed/32118391>

23\.      Ferro F, Elefante E, Baldini C, Bartoloni E, Puxeddu I, Talarico R, et al. COVID-19: the new challenge for rheumatologists. Clin Exp Rheumatol \[Internet]. 38(2):175–80. Available from: <http://www.ncbi.nlm.nih.gov/pubmed/32207680>

24\.      Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatology Venereol \[Internet]. 2020 Mar 26; Available from: <http://doi.wiley.com/10.1111/jdv.16387>

25\.      Grimalt DR. Skin manifestations in COVID-19 \[Internet]. Twitter. 2020 \[cited 2020 Apr 4]. Available from: <https://twitter.com/DrRamonGrimalt/status/1244588698047598592>

26\.      Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, Moreno-Arrones OM, Saceda-Corralo D, Arana-Raja A, et al. Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak. J Am Acad Dermatol \[Internet]. 2020 Apr; Available from: <https://linkinghub.elsevier.com/retrieve/pii/S019096222030709X>

27\.      Galván Casas C, Català A, Carretero Hernández G, Rodríguez‐Jiménez P, Fernández Nieto D, Rodríguez‐Villa Lario A, et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol \[Internet]. 2020 Apr 29;bjd.19163. Available from: <https://onlinelibrary.wiley.com/doi/abs/10.1111/bjd.19163>

28\.      Bouaziz J, Duong T, Jachiet M, Velter C, Lestang P, Cassius C, et al. Vascular skin symptoms in COVID‐19: a french observational study. J Eur Acad Dermatology Venereol \[Internet]. 2020 Apr 27;jdv.16544. Available from: <https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.16544>

29\.      Azzi L, Carcano G, Dalla Gasperina D, Sessa F, Maurino V, Baj A. Two cases of COVID‐19 with positive salivary and negative pharyngeal or respiratory swabs at hospital discharge: a rising concern. Oral Dis \[Internet]. 2020 Apr 25;odi.13368. Available from: <https://onlinelibrary.wiley.com/doi/abs/10.1111/odi.13368>

30\.      To KK-W, Tsang OT-Y, Yip CC-Y, Chan K-H, Wu T-C, Chan JM-C, et al. Consistent Detection of 2019 Novel Coronavirus in Saliva. Clin Infect Dis \[Internet]. 2020 Feb 12; Available from: <https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa149/5734265>

31\.      Thompson R, Cunniffe N. The probability of detection of SARS-CoV-2 in saliva. Stat Methods Med Res \[Internet]. 2020 Apr 26;29(4):1049–50. Available from: <http://journals.sagepub.com/doi/10.1177/0962280220915049>

32\.      Döhla M, Boesecke C, Schulte B, Diegmann C, Sib E, Richter E, et al. Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity. Public Health \[Internet]. 2020 May;182:170–2. Available from: <https://linkinghub.elsevier.com/retrieve/pii/S0033350620301141>

33\. SEIMC. Recomendaciones de SEIMC sobre el uso de la las pruebas de detección de anticuerpos. \[Internet]. 2020. Available from: <https://seimc.org>&#x20;

34\. Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for SARS-CoV-2. JAMA \[Internet]. 2020 May 6; Available from: <https://jamanetwork.com/journals/jama/fullarticle/2765837>

35\.      Xiong M, Liang X, Wei Y. Changes in Blood Coagulation in Patients with Severe Coronavirus Disease 2019 (COVID‐19): a Meta‐Analysis. Br J Haematol \[Internet]. 2020 Apr 18;bjh.16725. Available from: <https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16725>

36\.      Velavan TP, Meyer CG. Mild versus severe COVID-19: laboratory markers. Int J Infect Dis \[Internet]. 2020 Apr; Available from: <https://linkinghub.elsevier.com/retrieve/pii/S1201971220302770>

37\.      Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J \[Internet]. 2020 Apr 27;2001009. Available from: <http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01009-2020>

38\.      Mak JWY, Chan FKL, Ng SC. Probiotics and COVID-19: one size does not fit all. Lancet Gastroenterol Hepatol \[Internet]. 2020 Apr; Available from: <https://linkinghub.elsevier.com/retrieve/pii/S2468125320301229>

39\. SEMFYC. Continuidad asistencial al alta en pacientes con diagnóstico de neumonía por SARS-COV-2. Conciliación de la medicación. 2020.

40\.      Cook TM. Hypertension is a clinically important risk factor for severe illness and mortality in COVID‐19. Anaesthesia \[Internet]. 2020 Apr 27;anae.15103. Available from: <https://onlinelibrary.wiley.com/doi/abs/10.1111/anae.15103>

41\.      Favalli EG, Agape E, Caporali R. Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis. J Rheumatol \[Internet]. 2020 Apr 25;jrheum.200507. Available from: <http://www.jrheum.org/lookup/doi/10.3899/jrheum.200507>

42\. SEIMC.SEI. Recomendaciones de la SEIMC-SEI para la prevención frente al coronavirus SARS-COV-2 en pacientes inmunodeprimidos. 2020.

43\. Folkehelseinstituttet/Norwegian Institute of Public Health. The role of children in the transmission of SARS-CoV-2 (COVID-19) – a rapid review. 2020.

44\.      Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol \[Internet]. 2004 Jul;191(1):292–7. Available from: <http://www.ncbi.nlm.nih.gov/pubmed/15295381>

45\.      Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet \[Internet]. 2020;395(10226):809–15. Available from: <http://dx.doi.org/10.1016/S0140-6736(20)30360-3>

46\.      CDC. COVID-19 Pregnancy and Breastfeeding \[Internet]. Available from: <https://www.cdc.gov/coronavirus/2019-ncov/prepare/pregnancy-breastfeeding.html?CDC\\_AA\\_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fspecific-groups%2Fpregnancy-faq.html>

47\.      Yan J, Guo J, Fan C, Juan J, Yu X, Li J, et al. Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases. Am J Obstet Gynecol \[Internet]. 2020 Apr; Available from: <https://linkinghub.elsevier.com/retrieve/pii/S0002937820304622>

48\.      Lu Q, Shi Y. Coronavirus disease (COVID‐19) and neonate: What neonatologist need to know. J Med Virol \[Internet]. 2020 Mar 12;jmv.25740. Available from: <https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25740>

49\.      Hu X, Gao J, Luo X, Feng L, Liu W, Chen J, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vertical Transmission in Neonates Born to Mothers With Coronavirus Disease 2019 (COVID-19) Pneumonia. Obstet Gynecol \[Internet]. 2020 Apr;1. Available from: <http://journals.lww.com/10.1097/AOG.0000000000003926>

50\.      Lu Q, Shi Y. Coronavirus disease (COVID‐19) and neonate: What neonatologist need to know. J Med Virol \[Internet]. 2020 Mar 12;jmv.25740. Available from: <https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25740>

51\.    SEI. SEIP. AEP. Otros efectos de la pandemia de COVID-19: caída de las vacunaciones \[Internet]. 2020. Available from: <https://vacunasaep.org/profesionales/noticias/otros-efectos-de-la-pandemia-de-covid-19-caida-de-las-vacunaciones>

52\.    Ministerio de Sanidad Servicios Sociales e Igualdad. Prioridades del programa de vacunación durante el estado de alarma debido a COVID-19 \[Internet]. 2020. Available from: <https://www.mscbs.gob.es>

53\.     Ministerio de Sanidad Servicios Sociales e Igualdad. Recomendaciones sobre el uso de mascarillas en la comunidad en el contexto de COVID-19 \[Internet]. 2020. Available from: [www.mscbs.gob.es](http://www.mscbs.gob.es)